Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomised Trial Comparing Chemotherapy Mit CHOEP (Cyclophosphamid, Doxorubicin, Vincristin, Etoposid Und Prednison) In 21-Day Intervals In Standard And Escalated Doses In Patients Aged 18-60 Years Of Age With Aggresive Non-Hodgkin-Lymphomas Favourable Prognoses

NCT00053768 is registered in ClinicalTrials.gov with German High-Grade Non-Hodgkin's Lymphoma Study Group as lead sponsor.

NCT NCT00053768
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00053768 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomised Trial Comparing Chemotherapy Mit CHOEP (Cyclophosphamid, Doxorubicin, Vincristin, Etoposid Und Prednison) In 21-Day Intervals In Standard And Escalated Doses In Patients Aged 18-60 Years Of Age With Aggresive Non-Hodgkin-Lymphomas Favourable Prognoses
Lead sponsor
German High-Grade Non-Hodgkin's Lymphoma Study Group
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2002
Completion date
December 5, 2006
Enrollment
392 (actual)
Sites
175

Conditions

As the registry lists them; a condition with its own page is linked.

lymphoma